Of note, a heatmap based on GSEA showed several tumor-associated immune checkpoints, such as H2-Ab1, CD86, CD80, and CD276, CD274 (Pdl1), were downregulated upon Prmt3 deletion (Fig. 4C). Here, CD86 is linked to neoplasm.